Cancer Genetics, Inc. (CGIX) Starts Presentation at LD Micro Conference

Cancer Genetics is an emerging leader in DNA-based cancer diagnostics, servicing some of the most prestigious medical institutions in the world. The company’s tests target cancers that are difficult to diagnose and predict treatment outcomes. Cancer Genetics also offers a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals, as well as biopharma and biotech companies. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For more information, visit the company’s website at www.cgix.com